Frontiers in Clinical Drug Research: (Record no. 157659)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01461nam a2200205Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220322124638.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 210614s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-1-68108-754-2 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | LC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Atta-ur-Rahman (Ed.) |
| 245 #0 - TITLE STATEMENT | |
| Title | Frontiers in Clinical Drug Research: |
| Remainder of title | Diabetes and Obesity/ |
| Statement of responsibility, etc | Atta-ur-Rahman |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | UAE |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Name of publisher, distributor, etc | Bentham Science Publisher: |
| Place of publication, distribution, etc | Sharja, |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Date of publication, distribution, etc | 2020. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 219 pages |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE | |
| Volume number/sequential designation | Vol. 5 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Frontiers in Clinical Drug Research – Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.<br/> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Book |
| Source of classification or shelving scheme | Library of Congress Classification |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Library of Congress Classification | Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | 22/03/2022 | RM301.27.A88_2020 | P 2985 | 22/03/2022 | 22/03/2022 | Book |